Locations:
Search IconSearch
May 18, 2021/Neurosciences/Podcast

Vasculitis and Stroke Before Age 50: A Growing Concern (Podcast)

When to suspect vasculitis and how to treat it

The prevalence of stroke in young adults — those under age 50 — is on the rise. One reason is the increase in atherosclerotic risk factors in this population. Other etiologies include inherited thrombophilias and hypercoagulability disorders, valvular heart disease and — perhaps more notably —autoimmune causes such as vasculitis, which have been on the rise.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

The newest episode of Cleveland Clinic’s Neuro Pathways podcast reveals more about stroke in young patients. G. Abbas Kharal, MD, MPH, a cerebrovascular immunologist with Cleveland Clinic’s Neurological Institute, discusses:

  • How to classify cerebral vasculitis
  • When to refer a patient to a cerebrovascular immunologist
  • Brain biopsy, vessel wall imaging and other diagnostic tools
  • Pulse-dose steroids and other treatments
  • Effects of COVID-19 infection in this patient population

Click the podcast player above to listen to the episode now, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

Excerpt from the podcast

Dr. Kharal: When should we suspect vasculitis? It’s important to note when we have the right clinical presentation: a younger patient with headaches, subacute encephalopathy, a subacute decline, recurrent ischemic strokes that really don’t fit in one specific cerebrovascular territory, and other constitutional symptoms. That is when to think that there’s something inflammatory going on.

The initial tests that lead us to diagnose a vasculopathy are, first, a brain MRI showing that there are new ischemic infarcts, and then some sort of vessel imaging, be it a CTA or MRA, that can demonstrate if there is a vasculopathy at all. Often you’ll be able to identify large- and medium-sized vessels on a CTA or MRA. However, smaller vessels, particularly those that are a couple of hundred micrometers in diameter, the tertiary and quaternary branches, are better visualized on cerebral angiography or DSA [digital subtraction angiography].

Advertisement

Once you have imaging showing vessel irregularities and CT or MRI evidence of new acute infarcts, you’ve established that there is some form of vasculopathy. But you still have not diagnosed whether or not it is inflammatory! That’s a common mistake I see clinicians make. Someone will do an angiogram and see vascular irregularities and say, “This is suggestive of vasculitis.” However, all we can tell on an angiogram or any vessel imaging is whether or not there is a vasculopathy.

The presence of vasculitis requires either an inflammatory CSF or tissue diagnosis — or, particularly in secondary causes, elevated inflammatory markers or other inflammatory signs and symptoms.

Once you’ve established a diagnosis of inflammatory vasculitis, that is when you want to further determine whether it is primary or secondary.

Advertisement

Related Articles

scan of a human brain

Study Links ANNA1/Hu-IgG Paraneoplastic Neurological Syndromes With Longer Cancer Survival

Findings may have implications for understanding the disorders’ pathophysiology

portait of Dr. Jay Alberts against decorative background with podcast icon overlay
July 16, 2026/Neurosciences/Podcast

Reshaping Research With Our New Neurological Assessment Center (Podcast)

Routine capture of standardized neuroperformance data may expand and refine investigations

woman looking concerned as she listens to a doctor speak to her

Study Offers First Characterization of Patients With Nonspecific Presentations of Multiple Sclerosis

Nearly one-fifth of such cases fulfill 2024 McDonald criteria based on biomarkers

gamma knife machine

Stereotactic Radiosurgery Shows Strong Local Control in SCLC Brain Metastases

Adequate dosing may improve outcomes in well-selected patients, large Cleveland Clinic series suggests

portrait of Dr. Robert Bermel against a decorative backdrop with podcast icon overlay
July 2, 2026/Neurosciences/Podcast

Inside Our New Neurological Assessment Center (Podcast)

Reimagining the outpatient neurological visit with routine capture of neuroperformance data

woman in white medical coat typing on a laptop in lab setting
June 30, 2026/Neurosciences/Epilepsy

Online Tool Makes It Easier to Share and Analyze Data on Epilepsy-Related Cognitive Disorders

Free portal helps researchers classify and share data using the IC-CoDE framework

woman in wheelchair being wheeled into or out of an elevator

Key Rural-Urban Differences Revealed in U.S. Post-Acute Stroke Care

Large study shows rural patients are less apt to be discharged to inpatient rehab, hampering outcomes

portrait of Dr. Jeffrey Cohen against decorative background with podcast icon overlay
June 16, 2026/Neurosciences/Podcast

The Potential of CAR T-Cell Therapy in Multiple Sclerosis (Podcast)

Updates on this fast-evolving therapeutic landscape from a leading trialist

Ad